Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insulet

318.59
+2.300.73%
Post-market: 318.590.0140+0.00%19:37 EDT
Volume:376.88K
Turnover:120.18M
Market Cap:22.43B
PE:95.88
High:321.63
Open:315.40
Low:315.17
Close:316.29
52wk High:353.50
52wk Low:226.50
Shares:70.39M
Float Shares:70.08M
Volume Ratio:0.84
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.32
EPS(LYR):5.97
ROE:19.18%
ROA:7.75%
PB:15.33
PE(LYR):53.37

Loading ...

Leerink Partners Keeps Their Buy Rating on Insulet (PODD)

TIPRANKS
·
Oct 16

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 15

Will Insulet’s (PODD) Innovation Roadmap Reinforce Its Competitive Edge in Diabetes Technology?

Simply Wall St.
·
Oct 15

Leerink Partners Adjusts Price Target on Insulet to $355 From $339, Maintains Outperform Rating

MT Newswires Live
·
Oct 14

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

GlobeNewswire
·
Oct 13

Insulet price target raised to $365 from $350 at RBC Capital

TIPRANKS
·
Oct 10

RBC Lifts Price Target on Insulet to $365 From $350, Keeps Outperform Rating

MT Newswires Live
·
Oct 10

Insulet Corporation to Host Investor Day at Headquarters in Acton Massachusetts

Reuters
·
Oct 10

U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity

Reuters
·
Oct 10

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 10

How Investors Are Reacting To Insulet (PODD) Raising Guidance After Surging Q2 Revenue and New Product Launch

Simply Wall St.
·
Oct 04

Rothschild & Co Redburn Adjusts Price Target on Insulet to $370 From $350, Maintains Buy Rating

MT Newswires Live
·
Oct 03

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 03

Insulet Down Over 6%, on Pace for Largest Percent Decrease Since August 2024 -- Data Talk

Dow Jones
·
Oct 01

Goldman Sachs Adjusts Price Target on Insulet to $375 From $399, Maintains Buy Rating

MT Newswires Live
·
Oct 01

Insulet Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Sep 30

Insulet Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Sep 29

Insulet price target raised to $399 from $353 at Canaccord

TIPRANKS
·
Sep 29

Insulet (PODD) Receives a Buy from Canaccord Genuity

TIPRANKS
·
Sep 29

U.S. RESEARCH ROUNDUP-Amazon, Insulet, Vertex

Reuters
·
Sep 29